These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9625817)

  • 21. DNA methylation and cancer.
    Das PM; Singal R
    J Clin Oncol; 2004 Nov; 22(22):4632-42. PubMed ID: 15542813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.
    Esteller M; Sanchez-Cespedes M; Rosell R; Sidransky D; Baylin SB; Herman JG
    Cancer Res; 1999 Jan; 59(1):67-70. PubMed ID: 9892187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker.
    Tost J
    Methods Mol Biol; 2009; 507():3-20. PubMed ID: 18987802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [DNA methylation: an epigenetic process of medical importance].
    Rodríguez-Dorantes M; Téllez-Ascencio N; Cerbón MA; López M; Cervantes A
    Rev Invest Clin; 2004; 56(1):56-71. PubMed ID: 15144044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours.
    Esteller M; Herman JG
    J Pathol; 2002 Jan; 196(1):1-7. PubMed ID: 11748635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA methylation differences associated with tumor tissues identified by genome scanning analysis.
    Liang G; Salem CE; Yu MC; Nguyen HD; Gonzales FA; Nguyen TT; Nichols PW; Jones PA
    Genomics; 1998 Nov; 53(3):260-8. PubMed ID: 9799591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
    Catto JW; Azzouzi AR; Rehman I; Feeley KM; Cross SS; Amira N; Fromont G; Sibony M; Cussenot O; Meuth M; Hamdy FC
    J Clin Oncol; 2005 May; 23(13):2903-10. PubMed ID: 15753461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors.
    Paz MF; Avila S; Fraga MF; Pollan M; Capella G; Peinado MA; Sanchez-Cespedes M; Herman JG; Esteller M
    Cancer Res; 2002 Aug; 62(15):4519-24. PubMed ID: 12154064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
    J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [DNA methylation and neoplasms].
    Mares J; Sedlácek Z; Goetz P
    Cas Lek Cesk; 2000 May; 139(10):291-4. PubMed ID: 10953416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation and gene silencing in cancer: which is the guilty party?
    Clark SJ; Melki J
    Oncogene; 2002 Aug; 21(35):5380-7. PubMed ID: 12154400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma.
    Shieh YS; Shiah SG; Jeng HH; Lee HS; Wu CW; Chang LC
    Cancer; 2005 Sep; 104(5):1013-21. PubMed ID: 15999364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.
    Esteller M; Hamilton SR; Burger PC; Baylin SB; Herman JG
    Cancer Res; 1999 Feb; 59(4):793-7. PubMed ID: 10029064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter hypermethylation of multiple genes in astrocytic gliomas.
    Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
    Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of methylation in urological tumours.
    van der Heijden AG
    Arch Esp Urol; 2013 Jun; 66(5):432-9. PubMed ID: 23793761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation alterations in urothelial carcinoma.
    Neuhausen A; Florl AR; Grimm MO; Schulz WA
    Cancer Biol Ther; 2006 Aug; 5(8):993-1001. PubMed ID: 16775427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.